Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 45690 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 45959 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | 50958 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | BS4 | IL-17A | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | BS4 | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | BS4 | Untreated | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | HAHA | IFN-G | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | HAHA | IL-17A | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | HAHA | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | PAK | IFN-G | |
Reversed phase NEGATIVE ION MODE | N-ACETYL-L-ASPARTIC ACID (CAS# 997-55-7); (M-H)- | Peak area | PAK | Untreated |